MTA1 Expression Can Stratify the Risk of Patients with Multifocal Non-Small Cell Lung Cancers ≤3 cm

References

• Chen C, Huang X, Peng M, Liu W, Yu F, Wang X. Multiple primary lung cancer: a rising challenge. J Thorac Dis. 2019;11(Suppl 4):S523–523S536. doi:10.21037/jtd.2019.01.56
   PubMed Web of Science ®Google Scholar
• Schneider F, Dacic S. Histopathologic and molecular approach to staging of multiple lung nodules. Transl Lung Cancer Res. 2017;6(5):540–549. doi:10.21037/tlcr.2017.06.11
   PubMed Web of Science ®Google Scholar
• Park E, Ahn S, Kim H, et al. Targeted sequencing analysis of pulmonary adenocarcinoma with multiple synchronous ground-glass/lepidic nodules. J Thorac Oncol. 2018;13(11):1776–1783. doi:10.1016/j.jtho.2018.07.097
   PubMed Web of Science ®Google Scholar
• Thunnissen E, Beasley MB, Borczuk AC, et al. Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study. Mod Pathol. 2012;25(12):1574–1583. doi:10.1038/modpathol.2012.106
   PubMed Web of Science ®Google Scholar
• Detterbeck FC, Boffa DJ, Kim AW, Tanoue LT. The eighth edition lung cancer stage classification. Chest. 2017;151(1):193–203. doi:10.1016/j.chest.2016.10.010
   PubMed Web of Science ®Google Scholar
• Detterbeck FC, Nicholson AG, Franklin WA, et al. The IASLC lung cancer staging project: summary of proposals for revisions of the classification of lung cancers with multiple pulmonary sites of involvement in the forthcoming eighth edition of the TNM classification. J Thorac Oncol. 2016;11(5):639–650. doi:10.1016/j.jtho.2016.01.024
   PubMed Web of Science ®Google Scholar
• Lee JG, Lee CY, Kim DJ, Chung KY, Park IK. Non-small cell lung cancer with ipsilateral pulmonary metastases: prognosis analysis and staging assessment. Eur J Cardiothorac Surg. 2008;33(3):480–484. doi:10.1016/j.ejcts.2007.12.005
   PubMed Web of Science ®Google Scholar
• Naeli P, Yousefi F, Ghasemi Y, Savardashtaki A, Mirzaei H. The role of MicroRNAs in lung cancer: implications for diagnosis and therapy. Curr Mol Med. 2020;20(2):90–101. doi:10.2174/1566524019666191001113511
   PubMed Web of Science ®Google Scholar
• Amiri A, Pourhanifeh MH, Mirzaei HR, et al. Exosomes and lung cancer: roles in pathophysiology, diagnosis and therapeutic applications. Curr Med Chem. 2021;28(2):308–328. doi:10.2174/0929867327666200204141952
   PubMed Web of Science ®Google Scholar
• Zhu W, Li G, Guo H, et al. Clinicopathological significance of MTA 1 expression in patients with non-small cell lung cancer: a meta-analysis. Asian Pac J Cancer Prev. 2017;18(11):2903–2909. doi:10.22034/APJCP.2017.18.11.2903
   PubMedGoogle Scholar
• Kozower BD, Larner JM, Detterbeck FC, Jones DR. Special treatment issues in non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e369S–e399S. doi:10.1378/chest.12-2362
   PubMed Web of Science ®Google Scholar
• Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol. 2015;10(9):1243–1260. doi:10.1097/JTO.0000000000000630
   PubMed Web of Science ®Google Scholar
• Westaway DD, Toon CW, Farzin M, et al. The International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society grading system has limited prognostic significance in advanced resected pulmonary adenocarcinoma. Pathology. 2013;45(6):553–558. doi:10.1097/PAT.0b013e32836532ae
   PubMed Web of Science ®Google Scholar
• Warth A, Muley T, Kossakowski C, et al. Prognostic impact and clinicopathological correlations of the cribriform pattern in pulmonary adenocarcinoma. J Thorac Oncol. 2015;10(4):638–644. doi:10.1097/JTO.0000000000000490
   PubMed Web of Science ®Google Scholar
• Zhu X, Guo Y, Li X, Ding Y, Chen L. Metastasis-associated protein 1 nuclear expression is associated with tumor progression and clinical outcome in patients with non-small cell lung cancer. J Thorac Oncol. 2010;5(8):1159–1166. doi:10.1097/JTO.0b013e3181e04d98
   PubMed Web of Science ®Google Scholar
• Li J, Yang X, Xia T, Guan Y, Zhong N. Stage I synchronous multiple primary non-small cell lung cancer: CT findings and the effect of TNM staging with the 7th and 8th editions on prognosis. J Thorac Dis. 2017;9(12):5335–5344. doi:10.21037/jtd.2017.12.101
   PubMed Web of Science ®Google Scholar
• Cheng H, Lei BF, Peng PJ, Lin YJ, Wang XJ. Histologic lung cancer subtype differentiates synchronous multiple primary lung adenocarcinomas from intrapulmonary metastases. J Surg Res. 2017;211:215–222. doi:10.1016/j.jss.2016.11.050
   PubMed Web of Science ®Google Scholar
• Schneider F, Derrick V, Davison JM, Strollo D, Incharoen P, Dacic S. Morphological and molecular approach to synchronous non-small cell lung carcinomas: impact on staging. Mod Pathol. 2016;29(7):735–742. doi:10.1038/modpathol.2016.66
   PubMed Web of Science ®Google Scholar
• Murphy SJ, Harris FR, Kosari F, et al. Using genomics to differentiate multiple primaries from metastatic lung cancer. J Thorac Oncol. 2019;14(9):1567–1582. doi:10.1016/j.jtho.2019.05.008
   PubMed Web of Science ®Google Scholar
• Girard N, Ostrovnaya I, Lau C, et al. Genomic and mutational profiling to assess clonal relationships between multiple non-small cell lung cancers. Clin Cancer Res. 2009;15(16):5184–5190. doi:10.1158/1078-0432.CCR-09-0594
   PubMed Web of Science ®Google Scholar
• Jiang L, He J, Shi X, et al. Prognosis of synchronous and metachronous multiple primary lung cancers: systematic review and meta-analysis. Lung Cancer. 2015;87(3):303–310. doi:10.1016/j.lungcan.2014.12.013
   PubMed Web of Science ®Google Scholar
• Guo H, Mao F, Zhang H, Qiu Y, Shen-Tu Y. [Analysis on the prognostic and survival factors of synchronous multiple primary lung cancer]. Zhongguo Fei Ai Za Zhi. 2017;20(1):21–27. Chinese. doi:10.3779/j.issn.1009-3419.2017.01.03
   PubMedGoogle Scholar
• Ishikawa Y, Nakayama H, Ito H, et al. Surgical treatment for synchronous primary lung adenocarcinomas. Ann Thorac Surg. 2014;98(6):1983–1988. doi:10.1016/j.athoracsur.2014.07.006
   PubMed Web of Science ®Google Scholar
• Shimada Y, Saji H, Otani K, et al. Survival of a surgical series of lung cancer patients with synchronous multiple ground-glass opacities, and the management of their residual lesions. Lung Cancer. 2015;88(2):174–180. doi:10.1016/j.lungcan.2015.02.016
   PubMed Web of Science ®Google Scholar
• Trousse D, Barlesi F, Loundou A, et al. Synchronous multiple primary lung cancer: an increasing clinical occurrence requiring multidisciplinary management. J Thorac Cardiovasc Surg. 2007;133(5):1193–1200. doi:10.1016/j.jtcvs.2007.01.012
   PubMed Web of Science ®Google Scholar
• Murphy SJ, Aubry MC, Harris FR, et al. Identification of independent primary tumors and intrapulmonary metastases using DNA rearrangements in non-small-cell lung cancer. J Clin Oncol. 2014;32(36):4050–4058. doi:10.1200/JCO.2014.56.7644
   PubMed Web of Science ®Google Scholar
• Takamochi K, Oh S, Matsuoka J, Suzuki K. Clonality status of multifocal lung adenocarcinomas based on the mutation patterns of EGFR and K-ras. Lung Cancer. 2012;75(3):313–320. doi:10.1016/j.lungcan.2011.08.007
   PubMed Web of Science ®Google Scholar
• Yang H, Sun Y, Yao F, et al. Surgical therapy for bilateral multiple primary lung cancer. Ann Thorac Surg. 2016;101(3):1145–1152. doi:10.1016/j.athoracsur.2015.09.028
   PubMed Web of Science ®Google Scholar
• Shen J, Jin Z, Lv H, et al. PFKP is highly expressed in lung cancer and regulates glucose metabolism. Cell Oncol (Dordr). 2020;43(4):617–629. doi:10.1007/s13402-020-00508-6
   PubMed Web of Science ®Google Scholar
• Yang N, Li C, Han X, Feng Z, Qiu F, Han J. Associations of MTA1 expression with CT features, pathology and prognosis of elderly patients with non-small cell lung cancer. Oncol Lett. 2020;20(5):172. doi:10.3892/ol.2020.12034
   PubMed Web of Science ®Google Scholar